亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南惠誠醫藥科技有限公司  

生產和銷售各類原料藥及其中間體,如:奧利司他、新利司他、利拉列汀、曲格列汀琥珀酸鹽、苯甲酸阿格列汀、卡格列凈半水合物、磷酸奧司他韋、瑞舒伐他汀鈣及其中間體、磷酸肌酸二鈉鹽、阿地溴銨、噻托溴銨一水合物、依替唑侖、丙戊酸鈉、美沙拉嗪、腎上腺素系列等。

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:趙攀峰
  • 電話:0531-68659623
  • 郵件:sales@hc-pharm.com
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 硼替佐米中間體2 CAS號: 114457-94-2
硼替佐米中間體2 CAS號: 114457-94-2
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
品牌 惠誠
過期 長期有效
更新 2017-07-19 09:59
 
詳細信息

中文名稱: 硼替佐米中間體2

中文同義詞: 硼替佐米中間體2;N-(2-吡嗪基羰基)-L-苯丙氨酸;硼替佐米中間體;N-吡嗪羰基-L-苯基丙氨酸;硼替佐米中間體B;(S)-3-苯基-2-[(吡嗪-2-羰基)氨基]丙酸(硼替佐米中間體);硼替佐米雜質B;N-(吡嗪基羰基)-L-苯基丙氨酸

英文名稱: (S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID 

英文同義詞: (S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID ;(S)-3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic acid;Bortezomib Intermediate 2;N-Pyrazinylcarbonyl-L-phenylalanine;N-(2-Pyrazinylcarbonyl)-L-phenylalanine;N-(2-吡嗪基羰基)-L-苯丙氨酸; 硼替佐米中間體;(S)-3-Phenyl-2-(pyrazine-2-carboxaMido)propanoic acid;N-(2-pyrazinylcarbonyl)-

CAS: 114457-94-2

分子式: C14H13N3O3

分子量: 271.27132

用途:硼替佐米中間體;

©2025 濟南惠誠醫藥科技有限公司 版權所有   技術支持:化工網   訪問量:11467  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |